Human B-natriuretic peptide improves hemodynamics and renal function in heart transplant patients immediately after surgery

Journal of Cardiac Failure

Volumn 10, Issue 4, 2004, Pages 292-296

  Feldman, David S ^a,b   Ikonomidis, John S ^c   Uber, Walter E ^c   Van Bakel, Adrian B ^a   Pereira, Naveen L ^a   Crumbley III, Arthur J ^c   Tann, Stephen M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NONE

Author keywords

Congestive heart failure; Filling pressures; Renal failure; Volume overload

Indexed keywords

ADRENALIN; BRAIN NATRIURETIC PEPTIDE; CHLOROTHIAZIDE; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; FENOLDOPAM; FUROSEMIDE; GLYCERYL TRINITRATE; INOTROPIC AGENT; METOLAZONE; MILRINONE; NESIRITIDE; NORADRENALIN; VASOPRESSIN;

ADULT; AGED; ARTICLE; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART OUTPUT; HEART VENTRICLE OVERLOAD; HEMODYNAMICS; HUMAN; KIDNEY FAILURE; LUNG CAPILLARY PRESSURE; MALE; PRIORITY JOURNAL; URINE VOLUME;

BIOLOGICAL MARKERS; CARDIAC OUTPUT; COMBINED MODALITY THERAPY; DIURESIS; FEMALE; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; POSTOPERATIVE COMPLICATIONS; PULMONARY WEDGE PRESSURE; TIME FACTORS; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 4143057014     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2003.12.004     Document Type: Article

References (10)

1. International Heart Lung Database. 7th Report. 2000.
2. Young J.B., Abraham W.T., Warner Stevenson L., Horton D.P., Elkayam U. Bourge RC and the VMAC Investigators. Intravenous nesiritide vs. nitroglycerin for treatment of decompensated congestive heart failure. A randomized controlled trial. JAMA. 287:2002;1531-1540
3. Silver M.A., Horton D.P., Ghali J.K., Elkayam U. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol. 39:2002;798-803
4. Kook H., Kim S.W., Kang S.Y., Kim S.Z., Kim J.H., Choi K.C., et al. Cyclosporine impairs the guanylyl cyclase activity of the natriuretic peptide receptor in the glomerulus. Pharmacol Res. 42:2000;435-441
5. Stobierska-Dzierzek B., Awad H., Michler R.E. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol. 38:2001;923-931
6. Colucci W.S., Elkayam U., Horton D.P., Abraham W.T., Bourge R.C., Johnson A.D., et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med. 343:2000;246-253
7. Koller K.J., Goeddell D.V. Molecular biology of the natriuretic peptides and their receptors. Circulation. 86:1992;1081-1088
8. Grantham J.A., Borgeson D.D., Burnett J.C. Jr. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure. Am J Physiol. 272:(4 Pt 2):1997;R1077-R1083
9. Jensen K.T., Carstens J., Pedersen E.B. Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans. Am J Physiol. 274:(1 Pt 2):1998;F63-F72
10. McCullough P.A., Kuncheria J., Mathur V.S. Diagnostic and therapeutic utility of B-natriuretic peptide in patients with renal insufficiency and decompensated heart failure. Rev Cardiovasc Med. 5:2004;16-25